Treatment of kala-azar with oral fluconazole [9]

Lancet

Volumn 348, Issue 9027, 1996, Pages 614-

  Sundar, S ^a   Singh, V P ^a   Agrawal, N K ^a   Gibbs, D L ^a   Murray, H W ^a  

^a BANARAS HINDU UNIVERSITY   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE;

ADOLESCENT; ADULT; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; FEMALE; HUMAN; LEISHMANIASIS; LETTER; MALE; ORAL DRUG ADMINISTRATION; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD;

EID: 0029813583     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)64828-3     Document Type: Letter

References (4)

1. TJ Walsh C Gonzalez CA Lyman SJ Chanock PA Pizzo Invasive fungal infections in children: recent advances in diagnosis and treatment Adv Pediatr Infect Dis 11 1996 187 290
2. S Sundar K Kumar VP Singh Ketoconazole in visceral leishmaniasis Lancet 336 1990 1582 1583
3. HW Murray J Hariprashad RE Fichti Models of relapse of experimental visceral leishmaniasis J Infect Dis 173 1996 1041 1043
4. EJ Anaissie DP Kontoyiannis C Huls Safety, plasma concentrations, and efficacy of high-dose fluconazole in invasive mold infections J Infect Dis 172 1995 599 602